Cargando…

Clinical and economic benefits of a new paradigm of HCV diagnosis and treatment

INTRODUCTION: The current paradigm (CP) of hepatitis C virus (HCV) diagnosis and treatment in Italy’s National Health Service system has numerous steps. The European Association for the Study of the Liver recommends initiation of a pan-genotypic direct-acting antiviral regimen after a simple diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fagiuoli, Stefano, Ruggeri, Matteo, Aragao, Filipa, Blissett, Rob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AboutScience 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616196/ https://www.ncbi.nlm.nih.gov/pubmed/36627870 http://dx.doi.org/10.33393/grhta.2021.2183

Ejemplares similares

Benefits of ART simplification on adherence, clinical and economic outcomes
por: Vera, J, et al.
Publicado: (2012)

Sofosbuvir, a Significant Paradigm Change in HCV Treatment
por: McQuaid, Thomas, et al.
Publicado: (2015)

The new paradigm of economic complexity()
por: Balland, Pierre-Alexandre, et al.
Publicado: (2022)

The Economic Costs of Diabetes: Is It Time for a New Treatment Paradigm?
por: Herman, William H.
Publicado: (2013)

A new paradigm evaluating cost per cure of HCV infection in the UK
por: Barclay, Stephen T., et al.
Publicado: (2016)

New paradigm in the economic literature on global warming
por: Cuerdo-Mir, Miguel, et al.
Publicado: (2023)

Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study
por: Ruggeri, Matteo, et al.
Publicado: (2022)

Meet–Test–Treat for HCV management: patients’ and clinicians’ preferences in hospital and drug addiction services in Italy
por: Andreoni, Massimo, et al.
Publicado: (2022)

Economic study of the value of expanding HCV treatment capacity in Germany
por: Sbarigia, Urbano, et al.
Publicado: (2017)

Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
por: Walsh, Jessica A., et al.
Publicado: (2023)

Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for Untreated Severe Obstructive Sleep Apnoea/Hypopnoea Syndrome: A Simulated Cost-Utility Analysis from a National Health Service Perspective
por: Blissett, Deirdre B., et al.
Publicado: (2021)

Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries
por: Yeh, Eric J., et al.
Publicado: (2023)

Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines
por: Singh, Shakti, et al.
Publicado: (2016)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
por: Martin, Natasha K., et al.
Publicado: (2016)

New Tools in HCV Diagnosis, in Light of the Enhanced Awareness and the New Drugs for Treatment: SMARTube and Stimmunology
por: Gorodin, Svetlana, et al.
Publicado: (2013)

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England
por: Harris, R. J., et al.
Publicado: (2016)

A New Paradigm for the Treatment of Secondary Hyperparathyroidism
por: de Francisco, Angel L. M., et al.
Publicado: (2008)

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors
por: Kirkwood, John M., et al.
Publicado: (2012)

Implementation of HCV screening in the 1969–1989 birth-cohort undergoing COVID-19 vaccination: a pivotal study in Italy
por: D’Ambrosio, Roberta, et al.
Publicado: (2022)

RE-PERG, a new paradigm for glaucoma diagnosis, in myopic eyes
por: Mavilio, Alberto, et al.
Publicado: (2019)

Economic benefit of back titration in the treatment of hypertension in Jos, Nigeria
por: Okeahialam, Basil N, et al.
Publicado: (2017)

Entry inhibitors: New advances in HCV treatment
por: Qian, Xi-Jing, et al.
Publicado: (2016)

New treatments for HCV: Perspective from Asia
por: Yu, Ming‐Lung, et al.
Publicado: (2015)

Cracked tooth diagnosis and treatment: An alternative paradigm
por: Mamoun, John S., et al.
Publicado: (2015)

Clinical and Economic Benefits of Autologous Epidermal Grafting
por: Maderal, Andrea D, et al.
Publicado: (2016)

A new paradigm in the diagnosis of hereditary hemolytic anemia
por: Jung, Hye Lim
Publicado: (2013)

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates
por: Lens, Sabela, et al.
Publicado: (2022)

1483. Real-time Creation of HCV Treatment Cascades in Clinics to Improve HCV Treatment Rates Among Patients with HIV/HCV Co-infection
por: Wegener, Maximilian D, et al.
Publicado: (2023)

Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes
por: Wylezinski, Lukasz S., et al.
Publicado: (2019)

Opportunities for PET to deliver clinical benefit in cancer: breast cancer as a paradigm
por: Fleming, Ian N., et al.
Publicado: (2010)

The economic benefits of reducing physical inactivity: an Australian example
por: Cadilhac, Dominique A, et al.
Publicado: (2011)

Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2021)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
por: Turkova, Anna, et al.
Publicado: (2015)

Evaluation of a fitness intervention for new firefighters: injury reduction and economic benefits
por: Griffin, Stephanie C, et al.
Publicado: (2016)

Treatment Planning: A New Paradigm
por: Rosenberg, Paul A.
Publicado: (2007)

The bioeconomy in Spain as a new economic paradigm: the role of key sectors with different approaches
por: Ferreira, Valeria, et al.
Publicado: (2023)

Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection
por: Olea, Antonio, et al.
Publicado: (2018)

Recent Paradigm Shifts in the Diagnosis and Treatment of Rheumatoid Arthritis
por: Jung, Young Ok, et al.
Publicado: (2012)

HCV compliance and treatment success rates are higher with DAAs in structured HCV clinics compared to general hepatology clinics
por: Chehl, Navdeep, et al.
Publicado: (2019)

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort
por: Adland, Emily, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jefu8cjkqhc4vnb9l935im3hvc